apalutamide

FDA Drug Profile

apalutamide is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: tablet, film coated.

Drug details

Generic Name
apalutamide
Sponsor
Janssen Ortho LLC
NDC Codes
1
Dosage Forms
TABLET, FILM COATED
Active Ingredients
APALUTAMIDE

Indications and Usage

1 INDICATIONS AND USAGE ERLEADA is indicated for the treatment of patients with Metastatic castration-sensitive prostate cancer (mCSPC) Non-metastatic castration-resistant prostate cancer (nmCRPC) ERLEADA is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer. ( 1 ) non-metastatic castration-resistant prostate cancer. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.